SCIEX, a company founded in 1970 and based in the United States, operates within the manufacturing sector, specifically focusing on medical devices and equipment as well as biotechnology for pharmaceuticals. With an employee base ranging from 1,001 to 5,000, SCIEX generates significant revenue, reflecting its established presence in the industry. The company specializes in analytical technologies and solutions that support scientific research and development, particularly in the realm of biopharmaceuticals. A recent technical note published by SCIEX illustrates their expertise in capillary zone electrophoresis (CZE) methods, demonstrating the optimization of buffer components to enhance the separation of charge variants in Nanobody samples. This work emphasizes the importance of reproducibility and method development in analytical processes, showcasing SCIEX's commitment to providing reliable solutions for researchers in the biotech field. The company's documentation indicates a focus on improving assay reproducibility and minimizing variability in testing, which are critical factors in biopharmaceutical development.